0001628280-24-023668.txt : 20240515 0001628280-24-023668.hdr.sgml : 20240515 20240515191521 ACCESSION NUMBER: 0001628280-24-023668 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240513 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Makela Jan CENTRAL INDEX KEY: 0001951803 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 24953161 MAIL ADDRESS: STREET 1: 500 W. MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 4 1 wk-form4_1715814910.xml FORM 4 X0508 4 2024-05-13 0 0001932393 GE HealthCare Technologies Inc. GEHC 0001951803 Makela Jan 500 W. MONROE STREET CHICAGO IL 60661 0 1 0 0 CEO, Imaging 0 Common Stock, par value $0.01 per share 2024-05-13 4 M 0 20227 63.51 A 83575 D Common Stock, par value $0.01 per share 2024-05-13 4 S 0 20227 81.57 D 63348 D Common Stock, par value $0.01 per share 2024-05-15 4 M 0 8388 63.51 A 71736 D Common Stock, par value $0.01 per share 2024-05-15 4 M 0 25472 75.30 A 97208 D Common Stock, par value $0.01 per share 2024-05-15 4 M 0 33095 76.37 A 130303 D Common Stock, par value $0.01 per share 2024-05-15 4 S 0 66955 81.54 D 63348 D Employee Stock Option (right to buy) 63.51 2024-05-13 4 M 0 20227 0 D 2030-03-02 Common Stock, par value $0.01 per share 20227 8388 D Employee Stock Option (right to buy) 63.51 2024-05-15 4 M 0 8388 0 D 2030-03-02 Common Stock, par value $0.01 per share 8388 0 D Employee Stock Option (right to buy) 75.30 2024-05-15 4 M 0 25472 0 D 2033-03-01 Common Stock, par value $0.01 per share 25472 0 D Employee Stock Option (right to buy) 76.37 2024-05-15 4 M 0 33095 0 D 2031-07-01 Common Stock, par value $0.01 per share 33095 33096 D The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.84, inclusive. The Reporting Person undertakes to provide GE HealthCare Technologies Inc. ("GE HealthCare"), any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). The price reported represents the weighted average price of shares sold. These shares were sold in multiple transactions at prices ranging from $81.50 to $81.68, inclusive. The Reporting Person undertakes to provide GE HealthCare, any security holder of GE HealthCare, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 100% became exercisable on March 2, 2023. Award of an employee stock option with respect to GE HealthCare common stock, of which 100% became exercisable on March 1, 2024. Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% became exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024. /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact 2024-05-15